- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00744822
Vibration Response Imaging (VRI) in Lung Transplant Recipients
August 28, 2008 updated by: Hannover Medical School
This study is a prospective, multi-center study.
50 lung transplant recipients will be enrolled in the study.
Subjects will be selected from lung transplant recipients, who have undergone single or double lung transplantation during the last six months These patients will undergo a baseline VRI recording prior to the interventional procedure and a follow-up VRI at 1 hour after the interventional procedure.
Furthermore, the patients will be recorded at the designated follow-up periods of 1, 3 and 6-month (+ 7 days) post-baseline visit, as well as before and 1 hour after any recurrent interventional procedure
Study Overview
Status
Completed
Conditions
Detailed Description
- Study participants will be patients who have undergone lung transplantation during the last 6 months and are in a stable clinical position at the time of enrollment.
- Patients who meet the study inclusion and exclusion criteria will be enrolled in the study.
The enrolled patients will be recorded with the VRI at each occurrence in which the standard procedures are performed:
- Baseline after study enrollment (VRI Recording 1 + standard evaluations).
- At each follow-up visit [1, 3, 6 months after baseline visit] during the 6 month follow-up period of the study (VRI Recordings + standard evaluations (if possible)).
- In the event of bronchoscopic intervention, then before the interventional procedure (VRI Recording 1 + standard evaluations) and before any recurrent interventional procedures (VRI Recordings + standard evaluations) during the course of the study (6-month follow-up period).
- 1 hour after all bronchoscopic interventional procedures.
- In the event of an unanticipated visit, then a VRI recording will be performed (VRI Recordings + standard evaluations).
- All subjects will be recorded according to a standard procedure; moreover, it is essential that for each subject repeatable recordings will be performed in the same manner (i.e. breathing manner and matrix placement). Each VRI recording session will take ~15 minutes [the actual recording is ~2 minutes for placement and breathing/recording].
Standard evaluation procedures may include any of the following:
- Lung function tests (this test is required at all visits)
- Physical examination
- Bronchoscopy (e.g. transbronchial biopsy)
- CT-imaging
- Chest x-ray
- V/Q Scan (Baseline visit for single lung transplantation)
- Blood gases (this test is required at all visits)
- Blood tests
Study Type
Observational
Enrollment (Actual)
55
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hannover, Germany, 30625
- Hannover Medical School
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
50 lung transplant recipients will be enrolled in the study.
Subjects will be selected from lung transplant recipients, who have undergone single or double lung transplantation during the last six months
Description
Inclusion Criteria:
Subjects must meet all of the following inclusion criteria to be entered into the study:
- Able and willing to read, understand, and provide written Informed Consent
- Male or Female in the age range of 18-65 years
- Subject is a lung transplant recipient who underwent single or double lung transplantation within the last 6 months
- BMI > 19
- Height of >1.55 meters
- Stable clinical condition at study baseline evaluation
Exclusion Criteria:
Any of the following will exclude the subject from study:
- Intubated patients
- Chest wall deformation
- Spine deformation (including severe scoliosis)
- Hirsutism
- Potentially contagious skin lesion on the back
- Skin lesion that would interfere with sensor placement
- Cardiac pacemaker or implantable defibrillator
- Patient is pregnant as confirmed with urine pregnancy test
- Colonization of multi-resistant bacteria (MRSA) If the subject meets all of the inclusion criteria and none of the exclusion criteria, he/she is eligible to participate in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The primary study objective is to evaluate the ability of VRI lung images in single lung or double lung transplant recipients to assist the physician in detecting risk factors associated with lung transplantation during the six-month follow-up period
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The secondary objective is to compare evaluations of the lung VRI images with the results of other evaluation techniques [i.e. PFT, chest X-ray].
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Tobias Welte, MD, Hannover Medical School
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2006
Primary Completion (Actual)
March 1, 2007
Study Completion (Actual)
March 1, 2007
Study Registration Dates
First Submitted
August 28, 2008
First Submitted That Met QC Criteria
August 28, 2008
First Posted (Estimate)
September 1, 2008
Study Record Updates
Last Update Posted (Estimate)
September 1, 2008
Last Update Submitted That Met QC Criteria
August 28, 2008
Last Verified
December 1, 2005
More Information
Terms related to this study
Other Study ID Numbers
- 4066
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Transplantation
-
Astellas Pharma Europe Ltd.Active, not recruitingLiver Transplantation | Kidney Transplantation | Heart Transplantation | Lung Transplantation | Intestine TransplantationBelgium, Czechia, France, Germany, Italy, Poland, United Kingdom
-
Emory UniversityCompletedLiver Transplantation | Kidney Transplantation | Heart Transplantation | Lung Transplantation | Heart-Lung TransplantationUnited States
-
Astellas Pharma IncCompletedHeart Transplantation | Lung Transplantation | Pancreas (Including SPK) TransplantationFrance, United Kingdom, Taiwan, Belgium, Italy, Austria
-
Hannover Medical SchoolUnknownExercise Training | Lung Transplantation | Psychotherapy | Heart-Lung Transplantation | "Rehabilitation"Germany
-
University of AlbertaNatera, Inc.; One LambdaRecruiting
-
Universidad Complutense de MadridHospital Universitario 12 de OctubreRecruiting
-
KU LeuvenCompleted
-
Hopital FochCompleted
-
Emory UniversityTerminated
-
Hannover Medical SchoolCorscience, Inc.CompletedLung TransplantationGermany